Security key
76155X100
Revolution Medicines, Inc. - Common Stock (RVMD)
CUSIP: 76155X100
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 199,316,245
- Total 13F shares
- 199,291,356
- Share change
- +5,666,804
- Total reported value
- $15,874,866,294
- Put/Call ratio
- 15%
- Price per share
- $79.65
- Number of holders
- 385
- Value change
- +$489,477,380
- Number of buys
- 225
- Number of sells
- 137
Report period
Q4 2025
Institutions
385
Top holders
10
RVMD full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Revolution Medicines, Inc. SEC filings
Revolution Medicines, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76155X100
Recent filing periods:
Top shareholders of RVMD - Revolution Medicines, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Farallon Capital Partners, L.P. |
13D/G
|
Dapice Joshua J. |
7.5%
|
14,596,149
|
$1,499,170,464 | +$137,025,822 | 31 Dec 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
5%
from 13D/G
|
9,401,687
|
$439,058,770 | — | 30 Sep 2025 | |
| BAKER BROS. ADVISORS LP |
13D/G
13F
|
Company |
4.9%
|
9,455,357
|
$971,159,717 | +$9,283,443 | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
4.5%
from 13D/G
|
8,327,758
|
$388,906,300 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
|
Company |
3.6%
|
6,987,639
|
$717,700,402 | -$336,077,288 | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.9%
|
15,663,094
|
$731,466,490 | — | 30 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
5.7%
|
11,356,054
|
$530,307,153 | — | 30 Sep 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
3.8%
|
7,601,087
|
$354,970,763 | — | 30 Sep 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
3.1%
|
6,223,291
|
$290,627,690 | — | 30 Sep 2025 | |
| Bellevue Group AG |
13F
|
Company |
2.8%
|
5,573,838
|
$260,298,235 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
5,254,639
|
$245,391,641 | — | 30 Sep 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.4%
|
4,782,318
|
$223,335,000 | — | 30 Sep 2025 | |
| Alphabet Inc. |
13F
|
Company |
2.1%
|
4,133,277
|
$193,024,036 | — | 30 Sep 2025 | |
| BVF INC/IL |
13F
|
Company |
2%
|
3,974,913
|
$185,628,437 | — | 30 Sep 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.8%
|
3,650,342
|
$170,470,971 | — | 30 Sep 2025 | |
| Holocene Advisors, LP |
13F
|
Company |
1.7%
|
3,437,283
|
$160,521,116 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
3,145,640
|
$146,932,051 | — | 30 Sep 2025 | |
| Woodline Partners LP |
13F
|
Company |
1.5%
|
2,915,883
|
$136,171,736 | — | 30 Sep 2025 | |
| a16z Capital Management, L.L.C. |
13F
|
Company |
1.4%
|
2,748,523
|
$128,356,024 | — | 30 Sep 2025 | |
| Casdin Capital, LLC |
13F
|
Company |
1.3%
|
2,647,333
|
$123,630,451 | — | 30 Sep 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
1.3%
|
2,513,967
|
$117,402,259 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.3%
|
2,498,327
|
$116,671,883 | — | 30 Sep 2025 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Company |
1.2%
|
2,474,428
|
$115,555,788 | — | 30 Sep 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.88%
|
1,750,000
|
$81,725,000 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.82%
|
1,635,395
|
$76,372,947 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.72%
|
1,440,818
|
$67,276,999 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.72%
|
1,434,642
|
$66,997,809 | — | 30 Sep 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.67%
|
1,335,270
|
$62,357,109 | — | 30 Sep 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.66%
|
1,311,741
|
$61,189,778 | — | 30 Sep 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.61%
|
1,224,759
|
$57,196,309 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.59%
|
1,180,085
|
$55,109,970 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.55%
|
1,088,965
|
$50,854,666 | — | 30 Sep 2025 | |
| Caligan Partners LP |
13F
|
Company |
0.53%
|
1,064,249
|
$49,700,428 | — | 30 Sep 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.52%
|
1,043,720
|
$48,741,724 | — | 30 Sep 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.5%
|
997,455
|
$46,581,149 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.48%
|
951,490
|
$44,434,581 | — | 30 Sep 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.47%
|
928,123
|
$43,343,344 | — | 30 Sep 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.44%
|
868,724
|
$40,569,411 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.43%
|
859,548
|
$40,140,892 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.38%
|
753,867
|
$35,205,590 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.37%
|
738,026
|
$34,465,815 | — | 30 Sep 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.33%
|
657,176
|
$30,690,119 | — | 30 Sep 2025 | |
| First Turn Management, LLC |
13F
|
Company |
0.32%
|
643,050
|
$30,030,435 | — | 30 Sep 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.32%
|
630,000
|
$29,421,000 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.3%
|
597,455
|
$27,901,149 | — | 30 Sep 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
595,038
|
$27,788,217 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
529,270
|
$24,716,928 | — | 30 Sep 2025 | |
| MIC Capital Management UK LLP |
13F
|
Company |
0.26%
|
508,569
|
$23,750,172 | — | 30 Sep 2025 | |
| Checkpoint Capital L.P. |
13F
|
Company |
0.25%
|
492,300
|
$22,990,410 | — | 30 Sep 2025 | |
| COMERICA BANK |
13F
|
Company |
0.25%
|
490,216
|
$22,893,059 | — | 30 Sep 2025 |
Institutional Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q4 2025
As of 31 Dec 2025,
Revolution Medicines, Inc. - Common Stock (RVMD) was held by
385 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
199,291,356 shares.
The largest 10 holders included
VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, BlackRock, Inc., FMR LLC, Nextech Invest, Ltd., WELLINGTON MANAGEMENT GROUP LLP, Paradigm Biocapital Advisors LP, and Bellevue Group AG.
This page lists
385
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
318
Q4 2025 holders
385
Holder diff
67
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.